PTCH1 and neoplasm: In another study, circulating tumor cells (CTCs) from men with metastatic castration-resistant prostate cancer demonstrated significantly higher PTCH expression compared with prostate samples from normal individuals, with a positive correlation between higher PTCH expression and longer duration of androgen-targeted therapy [19].